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Abstract
Background: Genome-wide association studies (GWAS) have generated a wealth of valuable genotyping data for
complex diseases/traits. A large proportion of these data are embedded with many weakly associated markers that
have been missed in traditional single marker analyses, but they may provide valuable insights in dissecting the
genetic components of diseases. Gene set analysis (GSA) augmented by protein-protein interaction network data
provides a promising way to examine GWAS data by analyzing the combined effects of multiple genes/markers,
each of which may have only individually weak to moderate association effects. A critical issue in GSA of GWAS
data is the definition of gene-wise P values based on multiple SNPs mapped to a gene.
Results: In this study, we proposed an alternative restricted search approach based on our previously developed
dense module search algorithm, and we demonstrated it in the CATIE GWAS dataset for schizophrenia. Specifically,
we explored three ways of computing gene-wise P values and examined their effects on the resultant module
genes. These methods calculate gene-wise P values based on all the SNPs, the top ranked SNPs, or the most
significant SNP among all the SNPs mapped to a gene. We applied the restricted search approach and identified a
module gene set for each of the gene-wise P value data set. In our evaluation using an independent method,
ALIGATOR, we showed that although each of these input datasets generated a unique set of module genes, all of
them were significant in the GWAS dataset. Further functional enrichment analysis of these module genes showed
that at the pathway level, they were all consistently related to neuro- and immune-related pathways. Finally, we
compared our method with a previously reported method.
Conclusion: Our results showed that the approaches to computing gene-wise P values in GWAS data are critical in
GSA. This work is useful for evaluating key factors in GSA of GWAS data.
Background
Genome-wide association studies (GWAS) have emerged
as a powerful tool to examine the genetic components of
complex disease. During the past six years, GWA studies
have successfully uncovered a few thousands of markers/
genes that are associated with complex diseases/traits [1].
So far, most standard GWA studies have focused on
single marker based analysis and applied the genome-
wide significance cutoff P value 5 × 10-8 for detecting sig-
nificant markers; however, many weakly or moderately
associated markers (e.g., whose P values are between 0.05
and 5 × 10-8) may also provide valuable insights. These
markers have been generally missed in the standard
analysis.
Gene set analysis (GSA) of GWAS data provides an
alternative approach of assessing the joint effects of mul-
tiple genes [2], regardless of whether they are individually
significant or not. Complex diseases are likely caused by
multiple genes and markers, each of which may only con-
tribute weak to moderate effect. Given that these markers
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are biologically or functionally correlated, GSA would
increase the power to detect them in a typical GWAS
dataset [2]. GSA typically uses pathways or functional
categories of cellular processes to define gene sets, such
as those from the KEGG database [3] and the Gene
Ontology (GO) annotations [4]. Among the available
GSA methods, representative ones include the Gene Set
Enrichment Analysis (GSEA) of GWAS data [5], the
Association LIst Go AnnoTatOR (ALIGATOR) [6], and
the Gene set Ridge regression in ASsociation Studies
(GRASS) [7]. An advanced GSA approach is to use
protein-protein interaction (PPI) network data as the
platform to dynamically search for “gene sets”, namely
network modules, and perform an enrichment test for
association signals. Our dense module search of GWAS
association signals from PPI network is one of the first
methods[8]. Besides, Rossin et al. [9] used PPI network to
assess whether the association loci uncovered in standard
GWA studies are significantly connected through PPIs.
They adapted a straightforward way of defining subnet-
works [9], i.e., given a list of loci and the genes located in
them, “direct networks” and “indirect networks” are con-
structed based on the network data. However, the GWAS
data is not effectively incorporated in the process of net-
work building such that the moderately associated genes
(0.05 ~ 5 × 10-8) are still missed. Therefore, more com-
prehensive methods are in need to incorporate the
GWAS data with the PPI data to help construct, priori-
tize, and evaluate subnetworks for complex diseases.
In most of these GSA methods, a critical issue is how to
define the gene-wise P value, the P value representing the
association signal at each gene region. In a typical GWAS
data, statistics at the single nucleotide polymorphism
(SNP) level is used, but biological data (pathways or PPI
network) are typically annotated to genes/proteins. Thus,
there is a gap between marker’s significance and gene-wise
significance. A popularly applied method in the field is to
select the most significant SNP from the multiple SNPs
mapped to each gene and represent the gene by the smal-
lest P value [2,5,10]. Although this method is sensitive to
retain the association signals and is easy to implement,
this way of using the minimum P value bears intrinsic
biases, including gene length, SNP density, and/or linkage
disequilibrium (LD) structures[11]. Recently, several
reported methods aim to compute gene-wise P values,
such as GATES [12], which adapts the Simes’ test within
each gene, VEGAS [13], which builds on the multivariate
normal distribution and takes into account pairwise LD
values, and the SNP-set analysis [14]. Incorporation of
these methods into a gene set analysis of GWAS data can
reduce potential biases at the gene level and improve the
robustness of follow up analyses.
In this work, we proposed a restricted search strategy
to implement our previously developed dense module
search (DMS) method [8]. This new strategy could
greatly reduce the computational intensity problem. We
demonstrated this method in a GWAS dataset for schizo-
phrenia and explored three different ways to define gene-
wise P values. Our results showed that the way to define
gene-wise P values could affect the network-based analy-
sis substantially, and it also concluded that caution is
needed when designing and interpreting the results.
Materials and methods
GWAS dataset
We used the GWAS dataset for schizophrenia from the
Clinical Antipsychotic Trial of Intervention Effectiveness
(CATIE) project [15]. The CATIE project is a multiphase
randomized controlled trial initially designed to investigate
and improve the use of antipsychotic medications in treat-
ing schizophrenia patients. We included the samples
involving 738 schizophrenia patients and 733 controls,
which were genotyped by Perlegen Sciences using the
Affymetrix 500K and Perlegen’s custom 164K chip, result-
ing in ~446 k genotyped SNPs. A detailed description of
the samples can be found in reference [15]. We accessed
this dataset (Distribution 7.0) from http://www.nimhge-
netics.org/ through NIMH approval. Only the Caucasian
samples were used. We followed the pipeline of quality
control, including the selection of samples and markers, as
described in references [8,16,17].
Gene-wise P value
To compute gene-wise P values, given multiple SNPs
mapped to each gene, an ideal algorithm should account
for potential confounding factors, such as gene length,
SNP density, and LD structures. We incorporated the soft-
ware tool VEGAS [13] to compute the gene-wise P values.
VEGAS combines the information of multiple SNPs by
making use of simulations from the multivariate normal
distribution while explicitly accounting for the LD
between markers. We followed the default settings in
VEGAS; this default setting maps SNPs to genes with
50 kb extension of gene boundaries. The HapMap CEU
samples (http://www.hapmap.org/, release R2) were
selected to estimate the LD structure in our work, as we
only included the Caucasian samples in the CATIE data.
We explored three options in VEGAS to compute gene-
wise P values based on sets of SNPs: (1) using all the SNPs
mapped to a gene (hereafter denoted as “VEGAS-all”); (2)
using the top 10% SNPs based on SNP-level P values
(“VEGAS-top”); and (3) using the most significant SNP,
i.e., the SNP with the smallest P value (“minP”). Note that
the minP option is the same as the smallest P value strat-
egy widely used in many post-GWAS analysis methods.
We included it here to compare with the other, more
advanced approaches based on combining of multiple
SNPs.
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PPI dataset
Our background PPI network data were collected from
six public PPI databases: MINT, IntAct, DIP, BioGRID,
HPRD, and MIPS/MPact. We downloaded these data
from the Protein Interaction Network Analysis (PINA)
platform (March 2010) [18]. To ensure the reliability of
the PPI data, we explicitly included only interactions
that have experimental evidence and involve both inter-
actors from human genes. Self-interaction and dupli-
cates were removed. The final network included a total
of 10,377 nodes and 50,109 interactions.
Module search algorithm
We first overlaid the GWAS data onto the whole human
PPI network by assigning each node a z-score:
z = −1(1 − P) , where −1 is the inverse normal cumu-
lative density function and P is the gene-wise P value from
any one of the three methods. For a module with k genes,






k . The detailed module
construction process can be found in our previous work
[8]. Briefly, for a given “seed node”, a “best module” with
the maximum module score will be returned in the con-
text of the working parameters, i.e., d=2 and r>0.1. Here, d
is distance for the nodes to be included to the seed node
and r is the network score increment cutoff value.
The overall network weighted by the GWAS data
serves as the working background. The restricted search
strategy we proposed in this study is implemented as
follows. First, we ranked all the nodes in the network
according to their weights zi and started with the node
that had the highest score as the seed to perform a
module search. Once the module was generated, all the
nodes present in this module, including the seed node
itself, were then removed from the network, and the
rest of the network constituted the new background net-
work. A new module search round was started again,
with the highest scored node in the new background
network each time, until none of the nodes in the back-
ground network could generate a module with ≥5 nodes
(i.e., the minimum number of nodes we required to
define a module). This restricted strategy takes into
account every single node in the background network
but does not require using each of them as a seed node,
which has been implemented in our previous work.
Thus, this tactic could greatly reduce the computational
duty and also avoid the heavy redundancy of resultant
modules using our original algorithm.
Significance test
To estimate the significance of the resultant modules,
we calculated P values based on the module scores (Zm).
We adopted the method proposed in [19] to empirically
estimate the null distribution, which is assumed to be a
normal distribution. Specifically, we used the median-
centered module score to estimate the location para-
meters δ and s for the empirical null distribution using
the R package locfdr and computed standardized module
scores by ZS = (Zm’- δ)/s, where Zm’ is the median-cen-
tered module score. The final module P values were
obtained using the standard calculation, P(Zm) = 1-F
(ZS), where F is the normal cumulative density function.
The module P values were then used for significance
test of the resultant modules and help module selection.
Evaluation by ALIGATOR
We utilized the software tool ALIGATOR [6] to evaluate
the module gene sets. The algorithm of ALIGATOR is
initially designed to prioritize Gene Ontology (GO) cate-
gories using summary GWAS data at the SNP level. Build-
ing on a resampling strategy, ALIGATOR first pools all
the SNPs and their P values from the GWAS data and
builds the SNP collection. In each resample, the algorithm
randomly selects SNPs from the collection and records the
number of significant genes defined by the selected SNPs.
Here, significant genes were defined as those with at least
one SNP that has a P value less than a pre-defined cutoff
value, e.g., 0.05. The random selection process keeps run-
ning until the significant genes targeted by the selected
SNPs reaches the number of the significant genes in the
real case. After the resampling SNP set is constructed,
each of the GO categories are compared with the resample
data to obtain the number of significant genes. This
resampling process is repeated numerous times (e.g.,
50,000), resulting in the null distribution of the number of
significant genes in each GO category. Finally, an empiri-
cal P value can be computed for each GO category by
comparing the significant genes in the category in the real
case versus those in the resample sets.
In our application, instead of using GO categories, we
constructed new gene sets based on the module genes.
The module genes identified by each input dataset were
pooled as one gene set, and 3 module gene sets were
generated, corresponding to the input dataset of VEGAS-
all, VEGAS-top, and minP. As a comparison, we also
included the KEGG pathways (downloaded as of March,
2011) [3]. We restricted the KEGG pathway size (number
of genes in a pathway) to ≥5 and ≤300. In total, there
were 204 KEGG pathways plus 3 module gene sets col-
lected for the ALIGATOR analysis. We followed the ALI-
GATOR default definition of significant genes, i.e., genes
with at least one SNP having P <0.05, and we performed
the resampling 10,000 times. Multiple testing correction
by the Benjamini & Hochberg (BH) method [20] was
then conducted.
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Comparison with DAPPLE
We compared with another available network based GSA
method, “Disease Association Protein-Protein Link Eva-
luator (DAPPLE)” [9]. We applied DAPPLE to the
CATIE dataset. DAPPLE aims to evaluate whether genes
in association loci are significantly connected by PPI,
where the association loci are typically defined by the
standard single marker analysis of a GWAS dataset for a
complex disease/trait. Using the genes located in these
association loci, DAPPLE searches for two types of sub-
networks: a direct network, in which the input genes are
directly connected, and an indirect network, in which the
input genes are connected through a common interactor
[9]. Both networks are then evaluated by a permutation
test to assess their significance. Because the construction
process of the resultant subnetworks starts with the input
association genes/loci, the method relies heavily on the
input genes and can generate different subnetworks if the
input gene/locus list is changed. However, the ways to
define associated genes have not been standardized yet,
although all adopt a pre-defined hard cutoff. For exam-
ple, the widely applied method employs the cutoff of 5 ×
10-8, which is challenging in psychiatric diseases, because
the association signals are typically weak in psychiatric
GWAS datasets. Alternatively, a user-defined cutoff
value, which can be less strict yet arbitrary, could be
considered.
Functional evaluation
We performed pathway enrichment test of the three mod-
ule gene sets using the canonical KEGG pathways. The
hypergeometric test was implemented with the genes in
the network used as the gene universe and module genes
used as the genes of interest. Multiple testing correction
was performed using the Bonferroni method.
Results
Exploration of gene-wise P values
Using VEGAS, three sets of gene-wise P values were gen-
erated, each of which used the full set of SNPs, the top
10% of SNPs, and the most significant SNP among all the
SNPs mapped to a gene. Figure 1 shows the Q-Q plot of
each of these P value sets as well as the distribution
of gene-wise P values versus gene length. The Q-Q plot of
the VEGAS-all set showed a trend most closely located as
would be expected in random cases. Furthermore, this set
did not display any strong correlation with gene length
(Figure 1), indicating that the VEGAS-all set does not
have strong confounding factors. On the other hand, the
minP method generates the most inflated distribution, and
the gene-wise P values showed a strong correlation with
gene length, i.e., higher proportion of significant genes
were observed with larger gene length (Figure 1). The
behavior of the VEGAS-top set falls between those of the
other two methods: neither the Q-Q plot nor the correla-
tion with gene length showed strong inflation.
Dense module search for schizophrenia
For each of the three gene-wise P value sets, we applied
the restricted search strategy of DMS to construct candi-
date modules significantly enriched for schizophrenia. The
restricted strategy greatly reduced the space for available
seed nodes; thus, the executing time for a complete search
round is much shorter than the full search strategy. In
each set, we obtained the number of modules, the number
of significant modules, and the number of module genes
in the significant modules (Table 1).
To explore the results, we first compared the module
genes in each data set using the weighted DMS method.
As shown in Figure 1, the overlapped genes varied greatly
among the three data sets, indicating that the gene-wise P
value definition approach influenced the resultant sub-
networks substantially. When using the VEGAS-all
method, the smallest number of module genes were gen-
erated, as well as the number of significant modules,
compared to the other methods, while the minP method
generated the largest number of significant modules and
module genes. However, the minP method is prone to
potential biases, such as gene length, SNP density and
LD structure. Thus, the results in this minP set might be
inflated by these biases.
Validation by ALIGATOR
For each of the three resultant sets, we validated them
using ALIGATOR, along with the canonical KEGG path-
ways. As shown in Table 2, the three resultant module
gene sets, each of which contains module genes identified
using the VEGAS-all, VEGAS-top, and minP gene-wise
P values as node weights, showed the most significant
P values, especially when compared to KEGG pathways.
This indicates that all three gene sets were significantly
enriched with association signals for schizophrenia,
regardless of the methods to define gene-wise P values.
Interestingly, the significant pathways from KEGG
include several immune-related pathways, such as asthma
(hsa05310, P=8.0 × 10-4), cytokine-cytokine receptor
interaction (hsa04060, P=2.9 × 10-3), and intestinal
immune network for IgA production (hsa04672, P=5.5 ×
10-3). These findings confirm the previous knowledge
that schizophrenia is a complex disease involving
immune systems [11,21-24].
Exploration of module genes
At the gene level, module genes showed extreme con-
vergence of significant genes compared to the back-
ground genes in the network. Defining significant genes
as those whose gene-wise P values were less than 0.05,
we computed the proportion of significant genes in the
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Figure 1 Q-Q plot of gene-wise P values and their distribution versus gene length. The three rows of panels represent the method of
VEGAS-all, VEGAS-top, and minP, respectively. In each row (method), the left panel displays the Q-Q plot, while the right panel shows the
distribution of gene-wise P values versus gene length. In the right panel, gene length (X-axis) was separated to bins, each of which has 100
genes; the Y-axis shows the proportion of significant genes (denoted as “SigGenes”) in each length bin. SigGenes were defined as those with
gene-wise P values <0.05.
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module gene set and the background set for each of the
three input datasets. As shown in Figure 2, the module
gene sets had a high proportion of significant genes in all
three scenarios, with the VEGAS-all dataset showing the
largest difference. Note that the minP dataset of gene-
wise P values is possibly inflated (Figure 1), and consis-
tently, the minP weighted background network has a
higher proportion of significant genes compared to the
other two scenarios. In such a context, the high propor-
tion observed in minP module genes (83.4%, Figure 2)
should be interpreted with caution.
We observed several well-studied candidate genes for
schizophrenia in each of the three resultant module gene
lists, such as AKT1, DTNBP1, ESR1, FLNB, GRIN1, IL4,
NOS1AP, YWHAZ, and others. When compared to the
genes previously studied for associations with schizo-
phrenia as those deposited in the SzGene database [25], a
total of 27 module genes were found to have positive
association results (Table 3). Further examination of
these genes showed that only a few of them were simulta-
neously identified by all three gene-wise P value defini-
tion methods, while many genes were uniquely identified
in only one of the three scenarios (the second column in
Table 3). The diversity of the module genes suggests that
each of these approaches to define gene-wise P values
may have its own advantages in prioritizing candidate
genes for the disease, yet the methods also differ greatly
in the resultant gene sets.
Comparison with the existing method (DAPPLE)
DAPPLE requires a user-defined list of loci from the
GWAS dataset. In our case, the CATIE GWAS dataset
did not report any marker with significant P values at
5 × 10-8 [15], and no genes could be used for the DAP-
PLE method at this conventional definition. Therefore,
we manually selected the top 30 genes in each of the
three gene-wise data sets, regardless of cutoff values for
significance. Table 4 summarized the results using DAP-
PLE analysis. In the scenario of VEGAS-all top genes, a
total of 4 direct interactions involving 5 genes were iden-
tified. Six genes were prioritized that achieved a corrected
P value <0.05, all of which belong to the group of 30
input genes. In contrast, 18 of the 30 input genes were
included in our module gene list. In the scenario of
VEGAS-top genes, only one direct interaction and two
prioritized genes were reported. Meanwhile, 21 of the 30
genes were found in the module gene list. Finally, in the
scenario of minP genes, three direct interactions and
three prioritized genes were reported, while 19 of the 30
genes were found in our module gene list. These results
indicated that our DMS methods could effectively recruit
significant genes as compared to DAPPLE.
Functional enrichment test of the module genes
Our functional enrichment test of the module gene sets
showed that the neurotrophin signaling pathway
(hsa04722) was significantly enriched in all three gene
sets (Table 5). The neurotrophin pathway functions in
the differentiation and survival of neural cells, playing
significant roles in neural development. A total of 10, 17,
and 18 module genes from the three module gene sets,
VEGAS-all, VEGAS-top and minP, respectively, were
presented in this pathway. However, the diversity at the
gene level was high: only 3 genes were overlapped among
all three module gene sets in this pathway, further sup-
porting the rationality of functional analysis at the gene
set level. Interestingly, in the minP module gene set,
there were also two immune-related pathways signifi-
cantly enriched: the T cell receptor signaling pathway
(hsa04660) and the antigen processing and presentation
pathway (hsa04612).
Discussion
By taking advantage of our previously developed dense
module search method, we proposed an alternative search
strategy in this work and demonstrated it in the CATIE
GWAS dataset, one of the major available GWAS datasets
for schizophrenia. Additionally, we explored the different
options to define gene-wise P values, including the
VEGAS-all method, which built on all the SNPs mapped
to a gene, the VEGAS-top method, which used the top
10% SNPs mapped to a gene, and the minP method,
which used the most significant SNP. By applying our
restricted search strategy in each of the three data sets, we
showed that the VEGAS-all method generated the smallest
number of module genes and was least affected by other




# modules # significant modules # module genes
VEGAS-all 256 13 144
VEGAS-top 572 33 323
minP 703 36 319
Table 2 Analysis results of module gene sets and KEGG
pathways by ALIGATOR (PBH <0.2)
Gene set P PBH
$
VEGAS-all module genes 1.0 × 10-4 0.007
VEGAS-top module genes 1.0 × 10-4 0.007
minP module genes 1.0 × 10-4 0.007
Asthma (hsa05310) 8.0 × 10-4 0.040
Tryptophan metabolism (hsa00380) 1.7 × 10-3 0.068
Gap junction (hsa04540) 2.3 × 10-3 0.076
Cytokine-cytokine receptor interaction (hsa04060) 2.9 × 10-3 0.082
Intestinal immune network for IgA production
(hsa04672)
5.5 × 10-3 0.137
$P values were adjusted by Benjamini & Hochberg (BH) method [20].
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Figure 2 Proportion of significant genes in each module of gene sets. Significant genes were defined as those with gene-wise P values
<0.05. The proportion of significant genes in module genes and in the background genes in the network were shown for each scenario of
using VEGAS-all, VEGAS-top, and minP as input genes, respectively.
Table 3 Summary of module genes having positive association results in previous studies
Gene Module gene set$ # SNPs Chr. Start (bp) Stop (bp) PVEGAS-all PVEGAS-top PminP
NOS1AP a, m 125 1 160306204 160606437 0.005 0.007 1.07 × 10-4
PTGS2 t, m 14 1 184907591 184916179 0.013 8.5 × 10-4 1.07 × 10-5
TSNAX t 11 1 229731021 229768892 0.476 0.306 0.113
DISC1 m 106 1 229829183 230243641 0.349 0.100 0.004
FLNB a 47 3 57969166 58133017 0.030 0.034 0.007
GSK3B t 40 3 121028235 121295203 0.141 0.073 0.011
PDE4D m 193 5 58300622 59225378 0.277 0.018 6.16 × 10-5
IL4 a 12 5 132037271 132046267 0.069 0.019 0.007
DTNBP1 a 52 6 15631017 15771250 0.020 0.022 0.008
RPP21 t, m 48 6 30420915 30422611 0.014 0.001 1.04 × 10-4
LTA m 43 6 31648071 31650077 0.450 0.075 0.003
TNF m 43 6 31651328 31654091 0.598 0.184 0.003
ESR1 a, t, m 86 6 152053323 152466101 0.091 0.027 0.004
TBP t 13 6 170705395 170723872 0.031 0.019 0.010
EGFR t, m 72 7 55054218 55242525 0.556 0.294 0.026
YWHAZ a, t, m 17 8 102000089 102034745 0.857 0.685 0.268
GRIN1 a, t, m 3 9 139153429 139183029 0.016 0.005 0.004
ATE1 m 59 10 123492614 123677536 0.491 0.155 9.28 × 10-4
IFNG t, m 26 12 66834816 66839788 0.068 0.007 0.002
NOS1 m 45 12 116135361 116283965 0.643 0.315 0.028
DGKH t 68 13 41520888 41701888 0.106 0.031 0.002
AKT1 a, t 6 14 104306731 104333125 0.076 0.056 0.026
TP53 t, m 11 17 7512444 7531588 0.540 0.219 0.075
PRKCA t 129 17 61729387 62237324 0.995 0.857 0.029
MAG m 13 19 40474877 40496547 0.097 0.037 0.003
DNMT3B t, m 21 20 30813851 30860823 0.026 0.002 1.75 × 10-4
MYH9 m 37 22 35007271 35113927 0.050 0.017 5.75 × 10-4
$a: VEGAS-all; t: VEGAS-top; m: minP.
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potentially confounding effects such as gene length. The
other two methods resulted in similar numbers of module
genes. These results call for caution when selecting differ-
ent methods to compute gene-wise P values, which may
have significant influences on the resultant module genes
prioritized for the disease.
The restricted search strategy is intended to reduce the
overlap among modules. Assuming that a local environ-
ment of the background network includes 5 nodes,
namely A, B, C, D, and E. Starting from node A, a mod-
ule including A, B, C, and D would be generated at Zm
+1>Zm × (1+r). Starting from B, a module including B, C,
D, and E would be generated. In our previous strategy to
apply DMS, both modules would be reported, even
though they had 75% overlapping genes. In the current
strategy, to resolve the issue of overlap, we starts with the
node that has the highest weight, e.g., A, to search for the
module. And then we would remove the module genes
from the background network after it is done, e.g., the
nodes A, B, C, and D would be removed from the net-
work and, thus, from further analysis. In this way, the
module starting from B would not be reported, as most
nodes in it have already been removed from considera-
tion. This ensures that each node in the network could
be analyzed once and will be involved in only one mod-
ule. Both methods have their own advantages. The tradi-
tional one performs a comprehensive search and allows
every node in the network to have the chance of being a
seed. The computational intensity is high and redun-
dancy among modules is strong. Furthermore, the corre-
lation among modules posts challenges for the follow up
statistical tests when selecting modules. In contrast, the
restricted strategy is computationally efficient by gradu-
ally shrinking the background network, and it ensures
against physical overlap among modules. However, it
may miss moderately significant genes that cannot be
included in any module. In practice, either of the two
strategies can be selected depending on the specific aims
and project design.
Computation of gene-wise P values is one of the key
steps in most post-GWAS analyses. There have been sev-
eral methods and tools published to compute gene-wise
Table 4 Comparative results by DAPPLE for the top 30 genes in VEGAS-all, VEGAS-top, and minP data sets
VEGAS-all VEGAS-top minP
DAPPLE
# of direct interactions 4 1 3
# genes to prioritize 6 2 3
Mean associated protein direct connectivity 1.6 1.0 2.0
Mean associated protein indirect connectivity 58.1 6.1 7.5
DMS
# module genes 18 21 19
Table 5 Enriched KEGG pathways for module genes using the hypergeometric test
Pathway name (KEGG ID) Pathway size # module genes P PBonferroni
VEGAS-all
Neurotrophin signaling pathway (hsa04722) 116 10 6.96 × 10-5 0.007
Adipocytokine signaling pathway (hsa04920) 55 6 6.34 × 10-4 0.065
Cell cycle (hsa04110) 114 8 1.56 × 10-3 0.158
Chronic myeloid leukemia (hsa05220) 70 6 2.28 × 10-3 0.227
Vasopressin-regulated water reabsorption (hsa04962) 34 4 4.10 × 10-3 0.405
VEGAS-top
Cell cycle (hsa04110) 114 20 8.61 × 10-8 1.15 × 10-5
Neurotrophin signaling pathway (hsa04722) 116 17 1.14 × 10-5 1.51 × 10-3
Endometrial cancer (hsa05213) 49 8 1.31 × 10-3 0.173
RIG-I-like receptor signaling pathway (hsa04622) 50 8 1.50 × 10-3 0.196
Chronic myeloid leukemia (hsa05220) 70 9 3.69 × 10-3 0.479
minP
T cell receptor signaling pathway (hsa04660) 104 17 2.68 × 10-6 3.43 × 10-4
Neurotrophin signaling pathway (hsa04722) 116 18 2.91 × 10-6 3.69 × 10-4
Antigen processing and presentation (hsa04612) 59 12 8.58 × 10-6 1.08 × 10-3
Chronic myeloid leukemia (hsa05220) 70 13 1.03 × 10-5 1.28 × 10-3
Non-small cell lung cancer (hsa05223) 51 11 1.14 × 10-5 1.42 × 10-3
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P values. The most widely applied method in the field is
to select the SNP with the smallest P value among all
SNPs mapped to a gene, although this method is sub-
jected to several known biases, such as gene length, SNP
density, and the local LD structure. We selected VEGAS
because of its advantages, such as acceptable computa-
tion time (<12 hours for a typical GWAS dataset like in
our case) and no need of genotyping data. The rationale
of including two formulations in VEGAS is that using all
SNPs mapped to a gene (e.g., VEGAS-all method) is
comprehensive but considering all SNPs potentially
dilute the signals, while using part of the SNPs (e.g.,
VEGAS-top) may miss some informative SNPs but cap-
tures the most significant 10% SNPs for the computation.
However, VEGAS computes SNP-SNP matrix based on
pairwise LD values and could only deal with autosomal
SNPs. SNPs located on the sex chromosomes (X and Y)
are not applicable for VEGAS and were removed from our
network based analysis. Although these genes accounted
for only a small proportion (3.9%) in the PINA network
we used, more comprehensive algorithms that are able to
handle all genes in the genome is needed for future work.
The module genes we identified, in any scenario,
recruited neuro-related and/or immune-related genes
and pathways. All three sets of module genes include
well-studied candidate genes for schizophrenia (e.g.,
DTNBP1), glutamate receptors (e.g., GRIN1), several
genes located in the MHC region (e.g., HIST1H1A,
HIST1H1C, HIST1H2AB, HIST1H2BB, HLA-E), and
genes from the 14-3-3 protein family (e.g., YWHAQ,
YWHAZ). Interestingly, all three module gene sets con-
tain several genes in the MHC region, even though none
of these genes passed the significance test for single mar-
kers at 5 × 10-8. The MHC region has been shown to har-
bor significant association signals in a combinatory
analysis of three GWAS datasets for schizophrenia
[11,24]. The identification of these genes by our DMS
method further confirmed this signal. It also proved that
network based analysis could reveal markers that,
although they individually failed the single marker test,
their joint affects on the disease might be significant.
Conclusions
We proposed an efficient network-assisted framework to
identify candidate genes from GWAS data based on dense
module search algorithm. Augmented by functional anno-
tation as well as a priori knowledge about schizophrenia,
we explored the methods to compute gene-wise P values
based on multiple SNPs mapped to a gene and assessed
their effects on downstream analysis. In specific applica-
tions, caution is needed when selecting different search
strategies and methods for gene-wise P values. Future
work to compute gene-wise statistics for all genes in the
genome will further improve such applications.
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